Covid biotech Ellume Health placed in liquidation after rival buyer fails to pay up
Queensland biotech company Ellume Health, which just two years ago was riding high after winning a $300 million US government Covid contract, has been placed in liquidation after a takeover offer for the failed business fell through. The Australian arm of the global business entered voluntary administration last August. It subsequently emerged that it owed… Read more »